Anastasia Karafoulidou Selected Research

Anastasia Karafoulidou Research Topics

8	Infections 05/2009 - 10/2002
4	Hemophilia A (Haemophilia) 01/2010 - 01/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 08/2004 - 10/2002
2	Disease Progression 08/2004 - 10/2002
1	Bone Resorption 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2009
1	Hemorrhage 08/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009
1	Hepatitis C 05/2008
1	Hemolysis 05/2008
1	Anemia 05/2008
1	Inflammation (Inflammations) 06/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2007
1	Virus Diseases (Viral Diseases) 06/2007
1	Psoriatic Arthritis 06/2007
1	HIV Infections (HIV Infection) 06/2007
1	Exanthema (Rash) 06/2007
1	HIV Seropositivity 10/2002

2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 05/2009 - 10/2002
2	RNA (Ribonucleic Acid)IBA 08/2004 - 10/2002
1	Tartrate-Resistant Acid PhosphataseIBA 01/2010
1	Alkaline PhosphataseIBA 01/2010
1	OsteoprotegerinIBA 01/2010
1	Collagen Type I (Type I Collagen)IBA 01/2010
1	RANK LigandIBA 01/2010
1	OsteocalcinIBA 01/2010
1	Factor VIII (Coagulation Factor VIII)IBA 11/2009
1	recombinant factor VIII SQIBA 11/2009
1	Lansoprazole (Prevacid)FDA LinkGeneric 08/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2009
1	Proton Pump InhibitorsIBA 08/2009
1	Nucleic AcidsIBA 05/2009
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2009
1	antineoplaston A10 (A 10)IBA 10/2007
1	Methotrexate (Mexate)FDA LinkGeneric 06/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2007
1	Etanercept (Enbrel)FDA Link 06/2007
1	Indicators and Reagents (Reagents)IBA 01/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2002

3	Highly Active Antiretroviral Therapy (HAART) 01/2009 - 01/2004
3	Therapeutics 05/2008 - 10/2002
1	Art Therapy 08/2004
1	First Aid (Aids, First) 10/2002